Amid rising tariff uncertainty, Medtech manufacturers are increasingly considering Costa Rica as a strategic alternative to China for production. With its skilled workforce, tax incentives, and established medical device ecosystem, Costa Rica is becoming a key destination for global life sciences companies seeking stability and cost advantages.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,